Park KT - Search Results

1

Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.

Park KT, Heida A, van Rheenen PF. Park KT, et al. Inflamm Bowel Dis. 2017 Sep;23(9):E47. doi: 10.1097/MIB.0000000000001229. Inflamm Bowel Dis. 2017. PMID: 28816762 No abstract available.

2

Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review.

Park KT, Bass D. Park KT, et al. Inflamm Bowel Dis. 2011 Jul;17(7):1603-9. doi: 10.1002/ibd.21488. Epub 2010 Nov 4. Inflamm Bowel Dis. 2011. PMID: 21053357 Review.

3

Non-drug costs associated with outpatient infliximab administration in pediatric inflammatory bowel disease.

Wu M, Sin A, Nishioka F, Park KT. Wu M, et al. Among authors: park kt. Inflamm Bowel Dis. 2013 Jun;19(7):1514-7. doi: 10.1097/MIB.0b013e318281f4f1. Inflamm Bowel Dis. 2013. PMID: 23567783 Free PMC article.

4

Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Yang Z, Clark N, Park KT. Yang Z, et al. Among authors: park kt. Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028. Epub 2013 Jul 21. Clin Gastroenterol Hepatol. 2014. PMID: 23883663 Free PMC article.

5

Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease.

Park KT, Crandall WV, Fridge J, Leibowitz IH, Tsou M, Dykes DM, Hoffenberg EJ, Kappelman MD, Colletti RB. Park KT, et al. Inflamm Bowel Dis. 2014 May;20(5):946-51. doi: 10.1097/01.MIB.0000441349.40193.aa. Inflamm Bowel Dis. 2014. PMID: 24451222 Free PMC article. Review.

6

Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience.

Park KT, Sin A, Wu M, Bass D, Bhattacharya J. Park KT, et al. Inflamm Bowel Dis. 2014 Jul;20(7):1242-9. doi: 10.1097/MIB.0000000000000061. Inflamm Bowel Dis. 2014. PMID: 24846718 Free PMC article.

7

Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.

Sin AT, Damman JL, Ziring DA, Gleghorn EE, Garcia-Careaga MG, Gugig RR, Hunter AK, Burgis JC, Bass DM, Park KT. Sin AT, et al. Among authors: park kt. Inflamm Bowel Dis. 2015 Jun;21(6):1368-77. doi: 10.1097/MIB.0000000000000374. Inflamm Bowel Dis. 2015. PMID: 25839776 Free PMC article.

8

Spanish and English Language Symposia to Enhance Activation in Pediatric Inflammatory Bowel Disease.

Martin M, Garcia M, Christofferson M, Bensen R, Yeh AM, Park KT. Martin M, et al. Among authors: park kt. J Pediatr Gastroenterol Nutr. 2016 Nov;63(5):508-511. doi: 10.1097/MPG.0000000000001191. J Pediatr Gastroenterol Nutr. 2016. PMID: 27031374 Free PMC article.

9

Predictive Value of Fecal Calprotectin in Pediatric Graft-Versus-Host Disease.

Wadhwani SI, Nakayuenyongsuk W, Shinn L, Chase P, Kharbanda S, Bass D, Park KT. Wadhwani SI, et al. Among authors: park kt. J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):e208-e209. doi: 10.1097/MPG.0000000000001369. J Pediatr Gastroenterol Nutr. 2016. PMID: 27504814 No abstract available.

10

Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.

Picoraro J, Winberry G, Siegel CA, El-Matary W, Moses J, Grossman A, Park KT. Picoraro J, et al. Among authors: park kt. Inflamm Bowel Dis. 2017 Jan;23(1):174-180. doi: 10.1097/MIB.0000000000001002. Inflamm Bowel Dis. 2017. PMID: 28002131 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters